病例定义：青蒿素类药物治疗后迟发性溶血性贫血。
Case definition: postartemisinin delayed hemolysis.
机构信息
CENTERS FOR DISEASE CONTROL AND PREVENTION.
出版信息
Blood. 2014 Jul 10;124(2):157-8. doi: 10.1182/blood-2014-06-578922.
Abstract
In this issue of , Jauréguiberry et al appear to have proven that the hypothesis of early destruction of pitted erythrocytes is correct and propose a method for screening patients for this syndrome. Early destruction of pitted erythrocytes has been the leading hypothesis for postartesunate delayed hemolysis since it was first recognized a few years ago.
摘要
本期 杂志中，Jauréguiberry 等人似乎已经证明了早期点状红细胞破坏的假说成立，并提出了一种针对该综合征患者的筛查方法。自几年前首次发现以来，点状红细胞早期破坏一直是青蒿琥酯后迟发性溶血的主要假说。
相似文献
1
Case definition: postartemisinin delayed hemolysis.病例定义：青蒿素类药物治疗后迟发性溶血性贫血。
Blood. 2014 Jul 10;124(2):157-8. doi: 10.1182/blood-2014-06-578922.
2
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.青蒿琥酯延迟性溶血是与青蒿素类药物的救生效果相关的可预测事件。
Blood. 2014 Jul 10;124(2):167-75. doi: 10.1182/blood-2014-02-555953. Epub 2014 May 23.
3
Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.两名回国的加拿大旅行者接受蒿甲醚肠外治疗严重疟疾后的延迟性溶血
Am J Trop Med Hyg. 2015 Oct;93(4):819-21. doi: 10.4269/ajtmh.15-0268. Epub 2015 Aug 3.
4
Post-artesunate delayed haemolysis in severe imported Plasmodium falciparum malaria.青蒿琥酯治疗后严重输入性恶性疟原虫疟疾出现延迟性溶血。
Med J Aust. 2015 Nov 2;203(9):364. doi: 10.5694/mja15.00565.
5
Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.美国2008年和2013年接受青蒿琥酯注射治疗疟疾后出现迟发性溶血病例的最新情况
MMWR Morb Mortal Wkly Rep. 2014 Aug 29;63(34):753-5.
6
Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France.在严重输入性恶性疟原虫疟疾患者青蒿琥酯治疗后迟发性溶血且直接抗球蛋白试验阳性时，不使用皮质类固醇治疗可获得良好结局，法国。
Int J Infect Dis. 2023 Dec;137:144-148. doi: 10.1016/j.ijid.2023.10.018. Epub 2023 Nov 4.
7
[Severe imported Falciparum malaria treated with artesunate].青蒿琥酯治疗输入性重症恶性疟
Ann Biol Clin (Paris). 2012 Nov-Dec;70(6):733-40. doi: 10.1684/abc.2012.0761.
8
An old foe on peculiar paths: severe falciparum malaria in a Syrian refugee, possibly infected during migrant smuggling from Türkiye to Germany.一个走特殊路径的老对手：一名叙利亚难民感染严重的恶性疟原虫疟疾，可能是在从土耳其向德国偷渡期间感染的。
Infection. 2023 Oct;51(5):1583-1586. doi: 10.1007/s15010-023-02042-7. Epub 2023 May 24.
9
Parenteral Artesunate for Severe Imported Plasmodium falciparum Malaria in Children.儿童重症输入性恶性疟的蒿甲醚注射治疗
Pediatr Infect Dis J. 2016 Sep;35(9):1053-4. doi: 10.1097/INF.0000000000001231.
10
Intravenous artesunate for severe malaria in travelers, Europe.静脉注射青蒿琥酯治疗旅行者重症疟疾，欧洲。
Emerg Infect Dis. 2011 May;17(5):771-7. doi: 10.3201/eid1705.101229.
引用本文的文献
1
Therapeutic efficacy of pyronaridine-artesunate (Pyramax) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia.吡喹酮-青蒿琥酯（Pyramax）治疗埃塞俄比亚西北部哈穆西特健康中心无并发症恶性疟原虫感染的疗效。
Malar J. 2023 Jun 17;22(1):186. doi: 10.1186/s12936-023-04618-y.
2
Use of artesunate in the treatment of severe imported malaria in France: review of the effectiveness and real-life safety in two French university hospitals.在法国使用青蒿琥酯治疗重症输入性疟疾：两所法国大学医院的有效性和真实安全性回顾。
BMC Infect Dis. 2023 May 25;23(1):359. doi: 10.1186/s12879-023-08260-6.
3
Delayed Hemolysis With Parenteral Artesunate.注射用青蒿琥酯所致的迟发性溶血
Hosp Pharm. 2023 Jun;58(3):259-262. doi: 10.1177/00185787221142471. Epub 2022 Dec 13.
4
Imported severe Plasmodium falciparum infection in the first trimester of pregnancy complicated by post-artemisinin delayed hemolysis and intrauterine fetal death, a case report.妊娠早期输入性重症恶性疟原虫感染并发青蒿素后延迟性溶血和宫内死胎1例报告
Trop Med Health. 2023 May 12;51(1):25. doi: 10.1186/s41182-023-00510-2.
5
Post-Artesunate Delayed Hemolysis: A Review of Current Evidence.青蒿琥酯治疗后延迟性溶血：当前证据综述
Trop Med Infect Dis. 2023 Jan 7;8(1):49. doi: 10.3390/tropicalmed8010049.
6
Treatment for Severe Malaria: Post-Artesunate Delayed Haemolysis and Neutropenia.重症疟疾的治疗：青蒿琥酯治疗后延迟性溶血和中性粒细胞减少症
Healthcare (Basel). 2022 Feb 22;10(3):413. doi: 10.3390/healthcare10030413.
7
Delayed autoimmune haemolytic anaemia after artesunate therapy for severe malaria.青蒿琥酯治疗重症疟疾后发生迟发性自身免疫性溶血性贫血。
BMJ Case Rep. 2022 Jan 17;15(1):e245845. doi: 10.1136/bcr-2021-245845.
8
Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis.青蒿琥酯迟发性溶血后直接抗球蛋白试验结果的系统分析。
Malar J. 2021 Apr 29;20(1):206. doi: 10.1186/s12936-021-03735-w.
9
Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.两例重症恶性疟患者口服蒿甲醚-本芴醇治疗后发生迟发性溶血性贫血
Am J Trop Med Hyg. 2017 May;96(5):1185-1189. doi: 10.4269/ajtmh.16-0460. Epub 2017 Feb 13.
10
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.口服青蒿素联合疗法治疗单纯性恶性疟原虫疟疾后的溶血反应。
Emerg Infect Dis. 2016 Aug;22(8):1381-6. doi: 10.3201/eid2208.151905.
本文引用的文献
1
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.青蒿琥酯延迟性溶血是与青蒿素类药物的救生效果相关的可预测事件。
Blood. 2014 Jul 10;124(2):167-75. doi: 10.1182/blood-2014-02-555953. Epub 2014 May 23.
2
Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.非洲儿童重症疟疾应用注射用青蒿琥酯治疗后的迟发性溶血反应：一项双中心前瞻性研究。
J Infect Dis. 2014 Jun 15;209(12):1921-8. doi: 10.1093/infdis/jit841. Epub 2013 Dec 26.
3
Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria.患者因严重输入性恶性疟原虫疟疾而接受口服青蒿琥酯-咯萘啶治疗后出现溶血性贫血。
Infection. 2013 Aug;41(4):863-5. doi: 10.1007/s15010-013-0451-x. Epub 2013 Apr 4.
4
Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria--worldwide, 2010-2012.2010-2012 年期间，在使用青蒿琥酯治疗重症疟疾后出现迟发性溶血性贫血的全球报告。
MMWR Morb Mortal Wkly Rep. 2013 Jan 11;62(1):5-8.
5
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.青蒿琥酯与奎宁治疗非洲儿童重症恶性疟的疗效比较（AQUAMAT）：一项开放标签、随机临床试验。
Lancet. 2010 Nov 13;376(9753):1647-57. doi: 10.1016/S0140-6736(10)61924-1. Epub 2010 Nov 7.
6
Intravenous artesunate for the treatment of severe malaria.静脉注射青蒿琥酯治疗重症疟疾。
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1250-8. doi: 10.1345/aph.1M732. Epub 2010 Jun 15.
7
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.青蒿琥酯与奎宁治疗重症恶性疟的随机对照试验
Lancet. 2005;366(9487):717-25. doi: 10.1016/S0140-6736(05)67176-0.
8
A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen-positive and -negative erythrocytes.恶性疟原虫环状体感染红细胞表面抗原阳性和阴性红细胞的体内动力学比较。
Blood. 2001 Jul 15;98(2):450-7. doi: 10.1182/blood.v98.2.450.
9
The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.恶性疟原虫疟疾抗疟治疗后寄生虫清除的机制。
J Infect Dis. 2000 Aug;182(2):629-33. doi: 10.1086/315718. Epub 2000 Jul 28.
Zotero 插件